Relapsing Multiple Sclerosis Relapsing Remitting Relapsing Progressive clinical trials

Explore recruiting relapsing multiple sclerosis relapsing remitting relapsing progressive clinical trials.

Recruiting relapsing multiple sclerosis relapsing remitting relapsing progressive studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Relapsing Multiple Sclerosis Relapsing Remitting Relapsing Progressive trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effect of ozanimod on meningeal inflammation and glial activation in Multiple Sclerosis: one year phase 4 experimental study PROTOCOL CODE: OZA22 / IM047 - 048

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Relapsing Multiple Sclerosis Relapsing Remitting Relapsing Progressive trials by city

Relapsing Multiple Sclerosis Relapsing Remitting Relapsing Progressive in Toronto Relapsing Multiple Sclerosis Relapsing Remitting Relapsing Progressive in Vancouver Relapsing Multiple Sclerosis Relapsing Remitting Relapsing Progressive in Montreal Relapsing Multiple Sclerosis Relapsing Remitting Relapsing Progressive in Calgary Relapsing Multiple Sclerosis Relapsing Remitting Relapsing Progressive in Edmonton Relapsing Multiple Sclerosis Relapsing Remitting Relapsing Progressive in Ottawa Relapsing Multiple Sclerosis Relapsing Remitting Relapsing Progressive in Winnipeg Relapsing Multiple Sclerosis Relapsing Remitting Relapsing Progressive in Quebec City Relapsing Multiple Sclerosis Relapsing Remitting Relapsing Progressive in Hamilton Relapsing Multiple Sclerosis Relapsing Remitting Relapsing Progressive in Kitchener Relapsing Multiple Sclerosis Relapsing Remitting Relapsing Progressive in London Relapsing Multiple Sclerosis Relapsing Remitting Relapsing Progressive in Halifax Relapsing Multiple Sclerosis Relapsing Remitting Relapsing Progressive in New York Relapsing Multiple Sclerosis Relapsing Remitting Relapsing Progressive in Los Angeles Relapsing Multiple Sclerosis Relapsing Remitting Relapsing Progressive in Chicago Relapsing Multiple Sclerosis Relapsing Remitting Relapsing Progressive in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease